Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Thomas Jefferson University
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
National Cancer Institute (NCI)
Vanderbilt University Medical Center
Mayo Clinic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
Mayo Clinic
Fred Hutchinson Cancer Center